肾梗死 中国就医指南

Renal infarction is a rare but potentially serious condition characterized by ischemic necrosis of renal parenchyma due to abrupt occlusion of the renal artery or its branches—most commonly from embolic or thrombotic events. Unlike chronic renal ischemia, renal infarction presents acutely and demands prompt recognition to prevent irreversible loss of renal function, systemic complications (e.g., hypertension, acute kidney injury), or septic sequelae if infarcted tissue becomes infected. Pathogenesis centers on vascular obstruction: emboli—often originating from atrial fibrillation, valvular heart disease, or left ventricular thrombi—account for ~60–70% of cases; in situ thrombosis may occur in settings of vasculitis (e.g., polyarteritis nodosa), hypercoagulable states (e.g., antiphospholipid syndrome, malignancy), or trauma-related arterial injury. Less common causes include renal artery dissection, fibromuscular dysplasia, or paradoxical embolism via patent foramen ovale. Epidemiologically, renal infarction is underdiagnosed, with an estimated incidence of 0.03–0.1% among hospitalized adults undergoing abdominal imaging; it peaks in the sixth to seventh decades, with slight male predominance. Risk factors include cardiovascular comorbidities (atrial fibrillation, recent myocardial infarction, mechanical heart valves), inherited or acquired thrombophilias, active malignancy, endocarditis, and prior history of systemic embolism. Clinical presentation is highly variable: up to 30% of cases are asymptomatic and detected incidentally on CT or MRI; symptomatic patients typically present with sudden-onset flank or abdominal pain (often unilateral), low-grade fever, nausea, hematuria, and elevated lactate dehydrogenase (LDH) or D-dimer. Serum creatinine may remain normal initially—even with substantial infarct volume—making imaging (contrast-enhanced CT or MRI) essential for diagnosis. Delayed diagnosis increases risks of chronic kidney disease progression, hypertension secondary to renin-mediated activation, and reduced quality of life due to persistent pain, fatigue, anxiety about recurrent events, and limitations in physical activity or employment. Patients often experience significant psychological burden—including health-related anxiety and uncertainty—especially when underlying cardiac or thrombotic conditions require lifelong anticoagulation and multidisciplinary follow-up. Early intervention improves renal salvage potential, though functional recovery depends on infarct size, collateral circulation, and timeliness of reperfusion strategies. Long-term management emphasizes secondary prevention: anticoagulation (e.g., DOACs or warfarin), cardiovascular risk optimization, and surveillance for recurrence or contralateral involvement.

# 肾梗死治疗方案与费用明细（肾内科）

一、非手术/保守治疗方案

适用于早期诊断、梗死灶＜30%肾体积、无心源性栓塞高危因素者。

• •抗凝治疗（华法林或利伐沙班）：含INR监测（80–120元/次，每月2–4次）＋肝肾功能+凝血四项（260元/次）
• •对症支持：镇痛（酮咯酸注射液）、血压控制（ACEI/ARB类）、水化治疗
• •费用区间：首月3,200–6,500元；后续每月1,800–3,600元

二、介入/手术治疗方案

适用于大面积梗死伴持续疼痛、肾动脉主干或一级分支闭塞、抗凝失败者。

• •肾动脉取栓/溶栓术（DSA引导下）：含术前CTA（1,200元）、心电监护、造影剂、导管耗材
• •费用区间：总费用28,000–45,000元（含术前检查3,500元）

三、特殊复杂情况处理

合并房颤未抗凝、多发栓塞、急性肾损伤（AKI 3期）或双侧梗死：需ICU监护、CRRT支持、多学科会诊。

• •费用区间：日均8,000–15,000元，7–14天疗程约9–21万元

四、方案快速选择指南

• •预算有限/轻症：首选抗凝+门诊随访（年支出≤5万元）
• •中高风险/单侧主干闭塞：推荐介入取栓（性价比最优，避免肾切除）
• •双侧梗死/顽固性AKI：立即转入肾内科重症单元，启动CRRT联合抗凝